XPO5 and breast carcinoma: These findings were consistent with a study that revealed a strong association between the XPO5*rs34324334 variant and elevated risk of breast carcinoma in postmenopausal women with breast cancer (dominant model: OR = 1.76, p-value < 0.05) [46].